Back to Search
Start Over
Development of a salmon protein hydrolysate that lowers blood pressure.
- Source :
-
European Food Research & Technology . Aug2009, Vol. 229 Issue 4, p561-569. 9p. 2 Charts, 8 Graphs. - Publication Year :
- 2009
-
Abstract
- A salmon protein hydrolysate (SPH) was developed containing several angiotensin I-converting enzyme (ACE) inhibitory tripeptides the most abundant of which were Val-Leu-Trp, Val-Phe-Tyr, and Leu-Ala-Phe. Simulated digestion experiments showed that active constituents of SPH would survive in the digestive tract and be available for absorption into the bloodstream. In fact, ACE inhibitory activity was improved following simulated digestion suggesting that there were larger peptides in SPH that might contribute to bioactivity in vivo. A single oral dose (1,500 mg/kg body mass) of SPH significantly lowered blood pressure in spontaneously hypertensive rats (SHR). The treatment of SHR with either SPH fraction (<3,000 Da) or SPH fraction (>3,000 Da) reduced blood pressure. We conclude that the ability of SPH to lower blood pressure is due to a combination of ACE inhibitory tripeptides as identified, as well as additional unknown, peptide species that are generated during digestion of SPH in the gastrointestinal tract. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14382377
- Volume :
- 229
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- European Food Research & Technology
- Publication Type :
- Academic Journal
- Accession number :
- 44487021
- Full Text :
- https://doi.org/10.1007/s00217-009-1083-3